David Lubner

David C. Lubner serves as a member of Braveheart Bio’s board of directors. Mr. Lubner currently serves as a Venture Partner at RA Ventures. Mr. Lubner is also the Co-Founder, President, Chief Operating Officer and member of the board of directors of Surmount LLC, a private early development life sciences company. Previously, Mr. Lubner served as Executive Vice President and Chief Financial Officer of Ra Pharmaceuticals, Inc., which was acquired by UCB S.A. in April 2020. Prior to Ra Pharmaceuticals, he served as Chief Financial Officer of several biotech companies, including Chief Financial Officer of PharMetrics Inc., a healthcare informatics company, until it was acquired by IQVIA (formerly IMS Health) in 2005.

‍

Mr. Lubner is a former Certified Public Accountant and received a B.S. in business administration from Northeastern University and an M.S. in taxation from Bentley University.

‍